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Abstract 
Background and aims 
Obesity and cardiac left ventricular hypertrophy (LVH) are recognised independent risk factors in the 
development of heart failure (HF). However, the combination of these factors may exacerbate the onset 
of cardiovascular disease by mechanisms as yet unclear. LVH leads to significant cellular remodelling, 
including alterations in metabolism which may result in an inappropriate accumulation of lipids and 
eventual lipotoxicty and apoptosis. The aim of the study was to determine the impact of dietary 
manipulation on cardiac metabolism in the obese and hypertrophied heart. 
 
Methods and Results 
LVH was induced via aortic constriction (AC) in an experimental model of cardiac hypertrophy and 
animals subjected to 9 weeks of dietary manipulation with either a standard, high fat, or a sucrose 
containing Western-style diet (SD, HFD and WD, respectively). This latter diet resulted in accelerated 
weight gain in both LVH/AC and control animals. LVH was greater in AC animals fed a WD, and both 
control and AC animals from this diet showed a significant reduction in cardiac fatty acid oxidation and 
increased triacylglycerol content. Ceramide content was significantly increased in the WD groups, with 
no additional effect of LVH. Comparison with a model of HF induced by exposure to Doxorubicin and 
WD showed exacerbated remodelling of cardiac ceramide species leading to increased C16 and C18 
content.  
 
Conclusions 
These findings highlight the inappropriate accumulation and re-distribution of cardiac ceramide species 
in a diet-induced model of obesity and LVH, potentially increasing susceptibility to cell death. The 
combination of increased fat and sugar leads to greater pathological remodelling and may explain why 
this diet pattern is consistently linked with poor cardiovascular outcomes. 
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Introduction 
Left ventricular hypertrophy (LVH) is a common observation in individuals with obesity, and is 
positively associated with heart failure (HF) [1, 2]. Metabolic remodelling is an early feature of both 
LVH and HF, with a substantial body of evidence showing that this is characterised by a decline in fatty 
acid (FA) oxidation (FAO) and increased reliance on glycolytic substrates [3]. Paradoxically, several 
studies have suggested that supplying fat to the hypertrophied heart prevents the decline in FAO and 
attenuates the progression of LVH [4, 5]. However, more physiological diets such as a Western-diet 
(WD) – characterised by a moderate amount of fat and sugar – h ve shown negative effects on cardic 
structural and metabolic function in both the healthy or hypertrophied heart [6-11]. These findings 
suggest that ventricular remodelling is highly susceptible to dietary interventions, and that a modern 
WD of moderate fat and sugar may have a specific negative effect on the myocardium. 
 
Increased delivery and uptake of FAs – in addition to chronic changes in circulating hormones – leads 
to accumulation of triacylglycerol (TAG) in the obese heart [12]. The accumulation of TAG is due to 
divergence of FA uptake and oxidation. Evidence for this derived from observations that greater uptake 
of FAs via increased expression of the membrane FA translocase, CD36, or reduced mitochondrial 
uptake and oxidation of FAs, leads to cardiac TAG, diacylglycerol (DAG) and ceramide accumulation, 
and contributes to a lipotoxic phenotype [5, 13, 14]. The process of lipotoxicity has been recognised as 
an important pathological mechanism precipitating dysfunction in the obese or hypertrophied heart and 
is a process that contributes to HF in these conditions [14].   
 
Altered FA handling in both the obese and/or hypertrophied heart and the shunting of activated FAs to 
ceramide synthesis is an important step in lipotoxicity. Ceramide can be generated either through de 
novo synthesis requiring serine, palmitoyl-CoA and another fatty acyl-CoA species, or via recycling of 
more complex sphingolipid species, principally sphingomyelin (SM) [15]. Ceramides of differing chain 
lengths can be generated from corresponding dihydro-ce amides via the actions of dihydro-ceramide 
desaturase and also ceramide synthase (CerS) isoforms utilising sphingosine and cytosolic fatty acyl-
CoA species [15] leading to multiple ceramide species in the heart [16, 17]. Indeed, in human patients 
with severe HF, cardiac ceramides are increased and changes in individual serum ceramide species are 
observed [18]. Chronic changes to cardiac ceramide species either by diet or LVH may be linked with 
both HF incidence and progression. The aim of the study was to determine the impact of dietary 
manipulation on cardiac metabolism in the obese and hypertrophied heart, and whether metabolic 
variations induce changes in cardiac ceramide species. Additionally, we sought to examine if potential 
metabolic changes were exacerbated in a model of HF.  
Materials and Methods 1 
Ceramide standards (Cer(d18:1/16:0) [C16], Cer(d18:1/17:0) [C17], Cer(d18:1/18:0) [C18], 2 
Cer(d18:1/20:0) [C20] and Cer(d18:1/24:0) [C24]) were purchased from Avanti Polar Lipids 3 
(Alabaster, MA, USA). Solvents for HPLC were obtained from Fisher Scientific (Loughborough, UK). 4 
All other chemicals were purchased from Sigma unless otherwise stated. Male Sprague-Dawley rats 5 
(body weight 230-250 g) were obtained from Charles River Laboratories, Kent, UK. Rats had free 6 
access to food and water. Experimental protocols were approved by the University ethics committee 7 
and conformed to the UK Animals (Scientific Procedures) Act (ASPA) of 1986. 8 
 9 
Animal treatment  10 
Were possible, all procedures followed recommendations f r methodological rigor in preclinical 11 
cardiovascular studies [19]. Pressure-overload hypertrophy was induced surgically via abdominal aortic 12 
constriction (AC) as described previously [10]. Control (CON) animals underwent identical surgery but 13 
without AC.  14 
 15 
Animals were randomized to one of 3 dietary regimens: i) standard chow diet (SD, #801002), ii  high 16 
fat diet (HFD, #824053) or iii) Western Diet (WD, #824127), giving six experimental groups (n = 6 rats 17 
per group): CON-SD, CON-HFD, CON-WD, AC-SD, AC-HFD and AC-WD.  Diets were supplied by 18 
Special Diet Services (Witham, UK). Sample size was estimated from previous research within our 19 
laboratory [10]. Dietary constituents are shown in Table 1. The composition of the HFD and WD was 20 
chosen because they are a closer physiological representation of current diet patterns when compared 21 
to previous studies in this area, and hence increase relevance of the findings. Rats were maintained on 22 
the diets for 9 weeks.  23 
 24 
A separate group of animals fed a WD for 9 weeks were tr ated with Doxorubicin (DOX n = 6) via six 25 
intraperitoneal injections of 2.5 mg/kg over a course of 2 weeks for a total dose of 15 mg/kg to induce 26 
HF [20]. Researchers remained blinded to the intervention (diet and/or AC or DOX) until all results 27 
were processed. 28 
 29 
 30 
 31 
Heart extraction 32 
Rats were anaesthetised via an intraperitoneal injection of sodium thiopentone (0.5 ml/100 g). Hearts 33 
were rapidly excised and perfused briefly to rinse blood from the coronary circulation using a modified 34 
isovolumic Langendorff mode with Krebs-Henseleit bicarbonate (KHB) buffer [10] gassed with 95% 35 
O2/5% CO2 (37°C, pH 7.4).Ventricles were freeze-clamped using liquid nitrogen-cooled Wollenberger 36 
tongs and stored at -80C.   37 
 38 
Cardiac lipid extraction and analysis 39 
Frozen cardiac tissue was ground using a liquid nitrogen-cooled pestle and mortar. Total cardiac lipids 40 
were extracted from 300 mg powdered ventricular tissue according to the method of Bligh and Dyer 41 
[21]. Myocardial TAG were assayed using a Sigma kit (TR0100).  42 
 43 
Enzyme activities: 44 
The activities of medium-chain acyl-CoA dehydrogenase (MCAD) and citrate synthase (CS) were 45 
assayed in left-ventricular tissue as described previously [10].           46 
 47 
LC/MS detection of cardiac ceramide species 48 
Cardiac ceramide speci s were determined in tissue extracts using 300 mg tissue homogenised in PBS 49 
(pH 7.4). Ceramides were extracted and processed as described by Merrill et al [22]. Chromatography 50 
was performed on an Agilent 1100 series pump and autosampler system equipped with an ACE 5 µm 51 
C18 3x100 mm column (Hichrom Ltd., Berkshire, UK) and a SecurityGuardTM (Penomenex, UK) guard 52 
column with C18 4x2 mm cartridges (Phenomenex). Extracts were resuspended in 50% methanol. 53 
Sample injection volume was 10 µl. Mobile flow was deliv red at a rate of 0.5 ml/min. The  HPLC 54 
gradient was based on the method of Merrill et al. [22]. The HPLC was controlled using Chromeleon 55 
software (Dionex, UK). Electospray ionisation (ESI) TOF-MS spectra were acquired using an API 56 
QSTAR Pulsar i tandem mass spectrometer (AB Sciex Instruments) in the positive ion mode using a 57 
TurboIonSpray source. Standard curves for C16, C18, C20 and C24 ceramides relative to the C17 58 
ceramide internal standard were prepared and used to determine the concentration of analytes in c rdiac 59 
extracts.  60 
 61 
Statistical analyses 62 
Data are presented as mean ± SE. Multiple comparisons were performed by using a one-way ANOVA 63 
with post hoc Sheffé test. Data were analysed using IBM SPSS statistics (v. 23.0) with a statistical 64 
significant result defined as a P value < 0.05. 65 
Results 
Cardiac morphological and metabolic changes are exacerbated by a western diet 
CON-SD and AC-SD showed a 111% and 115% increase in body weight over the 9 week period, 
respectively. In contrast, CON-HFD and AC-HFD animals demonstrated a 136% and 119% increase in 
body weight over the 9 week period, respectively. Similar increases body weight were observed for the 
WD group (174% and 140%, CON and AC respectively) (Fig. 1). CON animals fed WD displayed a 
significant increase in terminal body weight in comparison to the CON-SD and CON-HFD groups. No 
significant difference were observed for AC groups. No significant differences in tibia length (TL) were 
observed between groups, suggesting that differenc s in body weight were not due to increases in lean 
body mass (results not shown). 
 
Heart weight was increased by AC in all dietary groups when compared to their respective controls. 
However, this increase only reached significance in SD and WD groups (P<0.05). Mean heart weight 
was 2.01 ± 0.1, 2.60 ± 0.1, 2.16 ± 0.1, 2.41 ± 0.2, 2.18 ± 0.2 and 2.65 ± 0.2 g in CON-SD, AC-SD, 
CON-HFD, AC-HFD, CON-WD and AC-WD groups, respectively). Heart weight did not differ 
significantly between control groups. When heart weight was normalised to TL as a marker of LVH 
[23] all AC groups showed a significant increase in the degree of hypertrophy when compared to their 
respective controls although this was more pronounced in the AC-WD group (Fig. 2A). 
 
No significant differences were found in MCAD activity between groups. Mean MCAD activity was 
12.0 ± 1.0, 11.0 ± 1.0, 13.4 ± 0.6, 12.1 ± 0.5, 13.8 ± 0.3 and 12.0 ± 0.4 µmol/min/g in CON-SD, AC-
SD, CON-HFD, AC-HFD, CON-WD and AC-WD groups, respectively. The HFD significantly 
increased CS activity in both CON and AC hearts when compared to the SD (73.4 ± 3.1 and 65.1 ± 2.4 
vs. 55.2 ± 2.9, 46.1 ± 1.8 µmol/min/g, respectively, P<0.05). WD feeding led to a significant increase 
(P<0.05) in CS activity in both CON and AC groups (101.4 ± 2.2, 96.2 ± 3.5 µmol/min/g, respectively) 
when compared to SD and HFD groups. These results in both the HFD and WD groups are suggestive 
of a specific mitochondrial biogenic response following these dietary feeding patterns. No differences 
in CS activity were observed between CON and AC groups within the same dietary regimen. The 
increase in CS activity coupled with unaltered MCAD activity suggested a decrease in the capacity for 
β-oxidation in WD hearts, shown by a reduced MCAD:CS ratio [24] (Fig. 2B). 
 
 
 
Myocardial triacylglycerol content is elevated in hearts from western diet-fed rats 
Cardiac TAG was significantly increased (P<0.01) by WD feeding in both CON and AC groups (2.4 ± 
0.1 and 2.3 ± 0.3 mol/g, respectively, ) when compared to their SD and HFD counterparts (1.6 ± 0.1, 
1.7 ± 0.1, 1.6 ± 0.1 and. 1.5 ± 0.2 mol/g, respectively). No intra-group differences were observed.   
 
Altered long-chain ceramide content in Western diet hearts  
No significant difference between any of the ceramide species measured in animals fed either a SD or 
HFD, or those subjected to AC (Fig. 3A-D). WD was associated with a substantial increase in all 
ceramides assayed, with no discernible difference between CON and AC groups (Fig. 3A-D). 
Irrespective of dietary intervention or AC, the predominant ceramide species measured was C24 (Fig. 
3D).  
 
Doxorubicin treatment specifically alters the cardiac lipid and ceramide profile associated with a 
western diet 
Administration of DOX led to deterioration in health including lethargy, poor coat condition and 
porphyrin staining around the nose and eyes, culminating in a 17% mortality.  
 
Cardiac TAG content was increased following DOX when compared to the CON group however this 
did not reach statistical significance (3.1 ± 0.6 vs. 2.3 ± 0.2 mol/g, respectively, P=0.06). This is likely 
due to a reduction in statistical power due to 17% mortality.  DOX treatment significantly increased 
total cardiac ceramide content when compared to the CON group, driven by significant increases in 
C16 and C18 ceramide (Fig. 4A-B). Concentrations of these ceramide species were increased 2.7- and 
3.4-fold following DOX treatment, respectively. C20 and C24 ceramide were unaltered by DOX 
treatment (Fig. 4C-D). Overall, DOX administration led to the greatest increase in cardiac ceramide 
(Fig. 4E).
Discussion  
The present study  demonstrated that a WD with modest amounts of fat and sug r can cause a substantial 
increase in the HW in animals subjected to AC and increases TAG content of both CON and 
hypertrophied hearts. The metabolic alterations of reduced capacity for FAO coupled with increased 
TAG are associated with a significant i crease in cardiac ceramide content which may render the heart 
more susceptible to apoptosis, cell loss and ultimately HF.  
 
Neither HW nor the HW:TL was altered by dietary intervention alone which is in contrast to recent 
work examining the effect of similar dietary interventions. Neves et al. [11] showed that left ventricular 
weight was increased by 12.5% in Swiss mice subjected to 16 weeks of similar dietary intervention, 
and Tikellis et al. [9] have observed myocyte hypertrophy following 16 weeks of a WD. The 
discrepancy between our data and previous work likely reflects differences in duration of study, age of 
animals used, the magnitude of sucrose or fructose consumption and source of dietary fat. Of particular 
interest in our study was the observed greater degree of hypertrophy in the AC-WD group. These 
observations suggest that WD combined with the stimulus for ventricular growth leads to a more 
pronounced hypertrophy. This is further supported by the blunted hypertrophic response seen in AC-
HFD animals.  Several mechanisms have been postulated to support this, including an important role 
of elevated plasma insulin and increased insulin signalling leading in accelerated protein synthesis and 
greater remodelling in animals fed a high carbohydrate diet [14]. We believe that a strength of our 
approach is the %kcal contributions from different macronutrients, which reinforces the relevance of 
the findings. In particular we observed that an increase from 9% to 14% of total calories from sucrose 
is sufficient to precipitate greater structural and metabolic remodelling.  
 
We also observed enzymatic changes which were largely dependent on the dietary intervention. 
Mitochondrial biogenesis was observed following both the HFD and WD in CON and AC animals 
(shown by an increase in CS activity) in comparison to SD counterparts. Mitochondrial transcription 
factor A (TFAM) has been shown to be increased in the hearts of animals fed a WD and may be due to 
oxidative stress generated from this dietary pattern [6, 8]. However, despite a biogenic response FAO 
in the WD-fed animals was reduced as measured by the MCAD:CS ratio, and was positively associated 
with TAG accumulation. The greatest reduction in FAO was found in the AC-WD group, consistent 
with others [3, 11]. The mechanism behind such a reduction remains unclear however inadequate 
activation of the transcription factor peroxisome proliferator- ctivated receptor α (PPARα) has been 
previously reported following WD [8] and thus may be the cause of the reduced FAO observed in both 
CON-WD and AC-WD groups. Our data clearly highlight the detrimental impact of increasing sucrose 
intake in combination with a moderate amount of fat. It would be prudent to examine the impact of the 
same percentage of dietary fat in combination with 0% sucrose on ventricular remodelling. 
 
Cardiac ceramide species were elevated in hearts from WD-fed animals. Mechanistically, the origin of 
the increase in cardiac ceramide species in our study remains undetermined. Alterations to cardiac acyl-
CoA species and therefore alterations to the cardiac acyl-CoA pool following the WD [7] could lead to 
increased shunting of these species into the de novo pathway of ceramide formation. This is supported 
by the observation that a WD decreases the conversion of palmitate to palmitoleic acid in the 
myocardium and reduces the ratio of MUFA:SFA, creating a palmitate-rich environment that favours 
ceramide formation [7]. We observed C24 ceramide to be the most predominant species in our platform 
of ceramides analysed, consistent with previous observations [16, 17]. Importantly, these studies 
demonstrate that ceramide remodelling extends further than the traditionally studied C16 ceramide and 
exposes the sole measurement of this sphingolipid as being of limited use.  
 
We further sought to set our results in the context of cardiac remodelling by utilising the DOX model 
of HF [20]. In this model we observed a specific increase in C16 and C18 ceramide. The rise in C16 
ceramide may be explained by the increase in palmitate observable following WD feeding [7]. The 
origins of the substantial increase in C18 ceramide are likely complex. It appears that the cardiotoxicity 
related to DOX is exacerbated in animals fed a HFD, mediated through increased oxidative stress and 
uncoupling of ATP provision, and decreased FAO [25]. Earlier studies have shown that a WD increases 
stearoyl-CoA [7] and DOX has been shown to activate ceramide synthase 1 (Cers1, responsible for the 
synthesis of C18 ceramide) [26]. Furthermore, the authors showed that this activation was associated 
with increased expression of p38 MAP kinase with the potential for enhanced apoptosis which could 
lead to impaired cardiac function. Combined with an increase in stearoyl-CoA following a WD, 
decreased FAO from DOX treatment and increased expression of CerS1 may explain the specific 
accumulation of C18 ceramide in the present DOX model.  
 
Strengths and limitations 
The benefits of the abdominal AC model of pressure overload model of LVH have been reviewed 
extensively [27], ultimately requiring a less severe surgical procedure and displaying a reduced 
mortality in comparison to more severe models of ventricular hypertrophy. Our labo atory has 
previously shown that this is a compensated cardiac phenotype useful for examining early changes in 
metabolism [10]. In comparison, transverse aortic constriction induces a much more severe cardiac 
response making it unsuitable for studying the early metabolic and physiological changes that occur 
during ventricular remodelling. Furthermore, because the rats used in the present study were 8 weeks 
of age at the time of the procedure, the abdominal banding leads to a gradual increase in afterload, 
mimicking progressive hypertension and increasing the translational nature of the findings.  
 
We chose to use a diet-induced model of obesity in order to maximise the translational impact of the 
findings. Indeed, common models such as ob/ob and db/db mice, in addition to the fa/fa rat which utilise 
disrupted  leptin signalling to induce hyperphagia and obesity – also can impact upon cardiac structure 
independently of body weight [28]. The strength of our approach was to utilise a rodent model where 
weight-gain was induced purely by diet, without any genetic manipulation. The composition of the HFD 
and WD was chosen because they are a closer physiological representation of current diet patterns and 
hence increase relevance of the findings. 
 
There are several limitations to our work that warrant discussion. We did not investigate changes in 
feeding behaviour between the different groups, however previous studies have shown a WD to be 
highly palatable [29]. Secondly, we utilised only male animals nd as such, these experiments should 
be repeated in female rodents. Thirdly, our results should be interpreted within the context of early 
ventricular remodelling, and may not represent changes in more severe LVH and HF. However, this 
may be regarded as a strength, as we show that even in an early compensated model, pathological 
alterations are observable which may precede the development of more severe structural and metabolic 
changes. Further studies are required to investigate if our observations translate into worse remodelling 
over a longer study duration. 
 
Conclusions 
Our data provide evidence that the WD is capable of inducing substantial metabolic remodelling in the 
heart when compared to both the SD and HFD, and is consistent with the concept of glucolipotoxicity. 
The WD led to the greatest weight gain, characterised by higher fat mass and central adiposity 
mimicking obesity. The novelty of our work highlights that changes in cardiac ceramide species are 
strongly influenced by diet and less- o by cardiac hypertrophy at this early stage of remodelling. Over 
time, chronic changes in ceramide may contribute to the transition from compensated hypertrophy to 
end-stage HF [30]. 
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Figure 1 
 
Fig. 1. Western diet feeding leads to significant body weight gain. Weekly body weights were 
assessed in male Sprague-Dawley rats after either aortic constriction (AC) or a control (CON) 
procedure and a standard, high-fat or western diet (SD, HFD and WD, respectively) for 9 weeks. Data 
are means ± SE of n = 6 animals per group. * = P<0.05 CON-HFD vs. AC-HFD; † = P<0.05 CON-
WD vs. AC-WD; ** = P<0.05 CON-WD vs. CON-SD and CON-HFD; § = P<0.05 AC-WD vs. AC-
SD and AC-HFD. 
Figure 2 
 
Fig. 2. Western diet regulates the cardiac response to aortic constriction and is associated with 
decreased capacity for fatty acid oxidation. A) Heart weight-to-tibia length and B) MCAD:CS ratios 
were determined in male Sprague-Dawley rats after either aortic constriction (AC, filled bars) or a 
control (CON, open bars) procedure and a standard,  high-fat or western diet (SD, HFD and WD, 
respectively) for 9 weeks. Data are means ± SE of n = 6 animals for SD groups, n = 6 for HFD 
groups, and n = 11 for CON-WD and n = 6 for AC-WD.  * = P<0.05 vs. respective control; ** = 
P<0.001 vs. respective control; † = P<0.05 vs. HFD and SD counterparts. 
 
 
 
Figure 4 
 
Fig. 4. Doxorubicin (DOX) administration to animals fed a Western diet leads to specific alteration in 
the cardiac long-chain ceramide pool. Myocardial content of C16 (A), C18 (B), C20 (C) and C24 (D) 
ceramide was analysed in cardiac extracts prepared from the hearts of male Sprague-Dawley rats after 
either doxorubicin (DOX, filled bars) or saline administration control (CON, open bars) and a western 
diet (WD) for 9 weeks. DOX administration led to the greatest increase in ceramide levels (E). Data 
are means ± SE of n = 6 for HFD groups, n = 11 for CON-WD, n = 6 for AC-WD and n=5 for DOX-
WD. * = P<0.01 vs. CON-WD; † = P<0.001 vs. HFD counterparts; # = P<0.05 vs. SD, HFD, CON-
WD, and AC-WD. 
Tables 
Table 1 Dietary macronutrient composition 
 
Diet 
SD 3.3 kcal/g HFD 4.54 kcal/g WD 4.56 kcal/g 
Dietary Component % (w/w) 
Energy 
(%) % (w/w) 
Energy 
(%) % (w/w) 
Energy 
(%) 
Carbohydrate (Total) 61.7 74.8 39.8 35.1 40.3 35.0 
Sucrose 4.1 5.0 10.5 9.3 16.0 13.9 
Protein (Casein) 14.4 17.5 23.0 20.0 23.0 20.0 
Fats (Total Lard + Soya 
Oil) 2.7 7.4 22.6 45.0 22.5 45.0 
Fibre 4.7 - 4.6 - 4.6 - 
SD, standard diet; HFD, high-fat diet; WD, western diet.  
 
 
 
 
 
 
 
 
